ID1 is also reported to be involved in TGFβ1-induced EMT activation, thus enhancing tumor progression in human cancer cells [40–44]; while inactivation of ID1 by inhibiting ID1 expression via berberine has potential therapeutic value against primary and metastatic growth of hepatocellular cancer [45]. Here, ID1 is linked to neoplasm.